Prosight Management, LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$333,000
-74.6%
20,000
-70.9%
0.22%
-72.6%
Q4 2021$1,313,000
-80.6%
68,800
-75.0%
0.79%
-78.9%
Q3 2021$6,776,000
+87.5%
274,761
+97.8%
3.73%
+65.0%
Q2 2021$3,614,000
-9.0%
138,886
+15.2%
2.26%
+19.7%
Q3 2020$3,970,000
-32.7%
120,606
-43.9%
1.89%
-25.5%
Q2 2020$5,902,000
-64.4%
215,000
-61.1%
2.53%
-67.3%
Q1 2020$16,557,000
+53.9%
553,100
+42.3%
7.74%
+63.9%
Q4 2019$10,756,000
+70.7%
388,600
+12.3%
4.72%
+35.1%
Q3 2019$6,300,000
-35.8%
346,149
-13.5%
3.50%
-29.3%
Q2 2019$9,808,000
+12.5%
400,000
-56.4%
4.94%
+29.6%
Q1 2019$8,721,000
-7.3%
917,080
-13.7%
3.82%
-21.4%
Q4 2018$9,403,000
+16.9%
1,062,500
+48.5%
4.85%
+8.2%
Q3 2018$8,047,000
+42.9%
715,317
+62.6%
4.49%
+8.7%
Q2 2018$5,631,000
+58.8%
439,900
+109.6%
4.13%
+85.6%
Q1 2018$3,546,000
-12.6%
209,842
-58.6%
2.22%
-25.4%
Q4 2017$4,055,000506,8522.98%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders